Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024 | ||||||||||||||||||||||||||||
By: PR Newswire Association LLC. - 20 Feb 2024 | Back to overview list |
|||||||||||||||||||||||||||
GAITHERSBURG, Md., Feb. 20, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its fourth quarter and full year 2023 financial results and operational highlights at 8:30 a.m. Eastern Standard Time (EST) on Wednesday, February 28, 2024. Details of the event and replay are as follows:
About Novavax
View original content:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2023-financial-results-and-operational-highlights-on-february-28-2024-302065938.html SOURCE Novavax, Inc. |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |